ATE59296T1 - Zusammensetzungen zur bekaempfung von toxaemia. - Google Patents
Zusammensetzungen zur bekaempfung von toxaemia.Info
- Publication number
- ATE59296T1 ATE59296T1 AT84307227T AT84307227T ATE59296T1 AT E59296 T1 ATE59296 T1 AT E59296T1 AT 84307227 T AT84307227 T AT 84307227T AT 84307227 T AT84307227 T AT 84307227T AT E59296 T1 ATE59296 T1 AT E59296T1
- Authority
- AT
- Austria
- Prior art keywords
- sup
- compositions
- toxaemia
- combating
- carbon atoms
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
- C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB838328111A GB8328111D0 (en) | 1983-10-20 | 1983-10-20 | Chemical compounds |
EP84307227A EP0139535B1 (de) | 1983-10-20 | 1984-10-19 | Zusammensetzungen zur Bekämpfung von Toxaemia |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE59296T1 true ATE59296T1 (de) | 1991-01-15 |
Family
ID=10550511
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT84307227T ATE59296T1 (de) | 1983-10-20 | 1984-10-19 | Zusammensetzungen zur bekaempfung von toxaemia. |
Country Status (10)
Country | Link |
---|---|
US (1) | US4626536A (de) |
EP (1) | EP0139535B1 (de) |
JP (1) | JPS60105618A (de) |
AT (1) | ATE59296T1 (de) |
AU (1) | AU3457384A (de) |
BE (1) | BE900856A (de) |
CH (1) | CH660970A5 (de) |
DE (2) | DE3483869D1 (de) |
GB (1) | GB8328111D0 (de) |
IT (1) | IT1178154B (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8617482D0 (en) * | 1986-07-17 | 1986-08-28 | Geistlich Soehne Ag | Pharmaceutical composition |
US5210083A (en) * | 1986-07-17 | 1993-05-11 | Ed. Geistlich Sohne A.G. Fur Chemische Industrie | Pharmaceutical compositions |
GB9005856D0 (en) * | 1990-03-15 | 1990-05-09 | Geistlich Soehne Ag | Compositions |
GB9600426D0 (en) * | 1996-01-10 | 1996-03-13 | Ed Geistlich Sohne A G | Compositions |
US6479481B1 (en) * | 1999-06-04 | 2002-11-12 | Ed. Geistlich Soehne Ag Fur Chemische Industrie | Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS) |
US8304390B2 (en) * | 1997-07-31 | 2012-11-06 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Method of treatment for preventing or reducing tumor growth in the liver of patient |
US20060199811A1 (en) * | 1997-07-31 | 2006-09-07 | Pfirrmann Rolf W | Method of treatment for preventing or reducing tumor growth in the liver of patient |
US20050124608A1 (en) * | 2001-04-03 | 2005-06-09 | Redmond H. P. | Treatment of cancers |
US6011030A (en) * | 1997-09-22 | 2000-01-04 | Ed. Geistlich Sohne Ag Fur Chemische Industrie | Method of treating symptoms of microbial infection or sepsis |
US5972933A (en) * | 1998-01-08 | 1999-10-26 | Ed. Geistlich Sohne Ag Fur Chemische Industrie | Method of treating microbial infections |
US6166007A (en) | 1998-07-02 | 2000-12-26 | Sodemann; Klaus | Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof |
US6821968B2 (en) * | 2001-09-26 | 2004-11-23 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Stable taurolidine electrolyte solutions |
US7892530B2 (en) | 1999-06-04 | 2011-02-22 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Treatment of tumor metastases and cancer |
US8030301B2 (en) | 1999-06-04 | 2011-10-04 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Treatment of cancers with methylol-containing compounds and at least one electrolyte |
US7345039B2 (en) * | 1999-06-04 | 2008-03-18 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer |
US6679870B1 (en) | 1999-07-23 | 2004-01-20 | Vasca, Inc. | Methods and kits for locking and disinfecting implanted catheters |
US6685694B2 (en) | 1999-07-23 | 2004-02-03 | Vasca, Inc. | Methods and kits for locking and disinfecting implanted catheters |
JP3213293B2 (ja) | 1999-08-02 | 2001-10-02 | 本田技研工業株式会社 | エンジン制御装置 |
DE60030770T2 (de) | 1999-12-06 | 2007-09-06 | Rhode Island Hospital | Verwendung von taurolidin oder taurultam zur herstellung eines medikaments zur behandlung von ovarialkarzinomen |
CN100519525C (zh) * | 1999-12-06 | 2009-07-29 | 葛兰素集团有限公司 | 芳香砜类及其医疗用途 |
US20020004502A1 (en) * | 2000-01-05 | 2002-01-10 | Redmond H. Paul | Treatment of inflammatory bowel disease |
US6641571B2 (en) | 2000-01-05 | 2003-11-04 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Reduction of postoperative complications of cardiopulmonary bypass (CPB) surgery |
EP1245247A1 (de) | 2001-03-28 | 2002-10-02 | Biolink Corporation | Biozidschleuse |
US20080171738A1 (en) * | 2001-04-03 | 2008-07-17 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Treatment of Breast Cancer |
JP5280603B2 (ja) | 2001-10-01 | 2013-09-04 | ガイストリッヒ ファーマ アーゲー | 転移阻害のための方法 |
US20050008684A1 (en) * | 2003-07-10 | 2005-01-13 | Claus Herdeis | Method of treatment for acne, rosacea and ulcers with taurolidine and/or taurultam in a pharmaceutical composition |
WO2005115357A2 (en) * | 2004-05-14 | 2005-12-08 | Hans-Dietrich Polaschegg | Taurolidine formulations and delivery |
US7696182B2 (en) | 2004-11-02 | 2010-04-13 | Nd Partners, Llc | Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin |
RU2624846C1 (ru) * | 2016-10-10 | 2017-07-07 | федеральное государственное бюджетное учреждение "Федеральный научно-исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации | Применение 4-(3-этокси-4-гидроксибензил)-5-оксо-5,6-дигидро-4Н-[1,3,4]-тиадиазин-2-(2,4-дифторфенил)-карбоксамида для подавления инфекции, вызванной устойчивыми к антибиотикам штаммами Pseudomonas aeruginosa, и способ подавления этой инфекции |
RU2737087C1 (ru) * | 2020-03-20 | 2020-11-24 | федеральное государственное бюджетное учреждение «Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи» Министерства здравоохранения Российской Федерации | Фармацевтическая композиция 4-(3-этокси-4-гидроксибензил)-5-оксо-5,6-дигидро-4h-[1,3,4]-тиадиазин-2-(2,4-дифторфенил)"карбоксамид в кристаллической форме, и ее применение в качестве антибактериального препарата для лечения острых, рецидивирующих и хронических инфекций |
US11738120B1 (en) | 2022-04-14 | 2023-08-29 | Cormedix Inc. | Synthesis of taurolidine, purity profiles and polymorphs |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1525296A (en) * | 1975-08-04 | 1978-09-20 | Geistlich Soehne Ag | Antibacterial compositions |
US4107305A (en) * | 1975-08-04 | 1978-08-15 | Ed. Geistlich Sohne A.G. Fur Chemische Industrie | Treatment of endotoxaemia |
-
1983
- 1983-10-20 GB GB838328111A patent/GB8328111D0/en active Pending
-
1984
- 1984-10-18 IT IT49031/84A patent/IT1178154B/it active
- 1984-10-19 DE DE8484307227T patent/DE3483869D1/de not_active Expired - Fee Related
- 1984-10-19 AT AT84307227T patent/ATE59296T1/de not_active IP Right Cessation
- 1984-10-19 EP EP84307227A patent/EP0139535B1/de not_active Expired - Lifetime
- 1984-10-19 CH CH5035/84A patent/CH660970A5/de not_active IP Right Cessation
- 1984-10-19 US US06/662,887 patent/US4626536A/en not_active Expired - Lifetime
- 1984-10-19 BE BE0/213859A patent/BE900856A/fr not_active IP Right Cessation
- 1984-10-19 JP JP59218751A patent/JPS60105618A/ja active Pending
- 1984-10-19 DE DE19843438469 patent/DE3438469A1/de not_active Withdrawn
- 1984-10-22 AU AU34573/84A patent/AU3457384A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0139535A2 (de) | 1985-05-02 |
DE3483869D1 (de) | 1991-02-07 |
AU3457384A (en) | 1986-04-24 |
CH660970A5 (de) | 1987-06-30 |
EP0139535B1 (de) | 1990-12-27 |
GB8328111D0 (en) | 1983-11-23 |
EP0139535A3 (en) | 1985-10-23 |
US4626536A (en) | 1986-12-02 |
IT1178154B (it) | 1987-09-09 |
JPS60105618A (ja) | 1985-06-11 |
DE3438469A1 (de) | 1985-05-09 |
IT8449031A1 (it) | 1986-04-18 |
IT8449031A0 (it) | 1984-10-18 |
BE900856A (fr) | 1985-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE59296T1 (de) | Zusammensetzungen zur bekaempfung von toxaemia. | |
JPS5671074A (en) | 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative | |
US4476308B1 (de) | ||
ATE89731T1 (de) | Zusammensetzungen zur propylaktischen behandlung von osteitis und osteomyelitis. | |
GR3001506T3 (en) | N-containing heterocyclic compounds, processes for the preparation thereof and composition comprising the same | |
DE3362504D1 (en) | 1-carboxyalkanoylindoline-2-carboxylic-acid esters, their preparation, pharmaceutical compositions containing them, and their therapeutic use | |
AU558261B2 (en) | Dialkylaminoalkyoxybenzylalcohol derivatives | |
ES8306994A1 (es) | Procedimiento para la obtencion de diamidas de acido hidroxi-maloico sustituidas. | |
ES8300097A1 (es) | "un procedimiento para preparar derivados de halofenil-piridil-alilamina". | |
IL70082A0 (en) | 1-aroyl-5-oxo-2-pyrrolidinepropanoic acids and salts and esters thereof,their preparation and pharmaceutical compositions containing them | |
ES8702392A1 (es) | Un procedimiento para preparar compuestos heterociclicos, en particular compuestos con un anillo de tiadiazinona | |
KR910006217A (ko) | 디히드로카페인산 유도체 및 이를 함유하는 약학제제 | |
DK159649C (da) | 4-hydroxy-alfa-benzhydrolderivater, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende disse, samt fremgangsmaade til fremstilling af disse farmaceutiske praeparater | |
KR840000235A (ko) | 치환 히드록시벤젠류에 의한 2-레노일메르캅토프로피온일글리신의 에스테르 제조방법 및 이를 함유한 약제조성물 | |
ES8502990A1 (es) | Procedimiento para preparar derivados de (x)-cianidan-3-ol. | |
ES8500619A1 (es) | Procedimiento de preparacion de derivados de eburnano-oxima racemicos u opticamente activos. | |
IE880226L (en) | 2-(2,2-difluorocyclopropyl) alkyl esters | |
KR900003162A (ko) | 비스(메틸렌디옥시)비페닐 화합물 | |
ES8403135A1 (es) | Un procedimiento para la preparacion de acido 6,-metoxi-6, -2-2-metilfenoxicarbonil-2-(tien-3-il) acetamido penicilanico. | |
KR920000327A (ko) | 비스(3,5-디-알킬-4- 히드록시페닐티오) 메탄을 유효 성분으로 함유하는 고트리글리세리드혈증 치료용 제약 조성물 | |
ES8201152A1 (es) | Procedimiento para la preparacion de acidos 5-sulfamoilorta-nilicos | |
WO1987003596A3 (fr) | Nouveaux composes phosphores et medicaments les contenant | |
FI943596A (fi) | Menetelmä terapeuttisesti käytt¦kelpoisten makrolidiyhdisteiden valmistamiseksi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |